Immunogenicity of DNA vaccine expressing ESAT6-CFP10 fusion protein of Mycobacterium tuberculosis

Hai ZHANG,Chang-Hong SHI,Li-Mei WANG,Ying XUE,Yin-Lan BAI,Zhi-Kai XU

DOI: https://doi.org/10.3321/j.issn:1000-2790.2007.06.003

2007-01-01

Abstract:AIM: To evaluate the humoral and cellular immune response induced by the DNA vaccine expressing ESAT6-CFP10 fusion protein and to test its protective efficacy against Mycobacterium tuberculosis(MTB) challenge. METHODS: BALB/c mice were immunized intramuscularly three times with 100 μg recombinant plasmid pcDNA-e6c10. Two weeks after last immunization, the specific antibody titer and the stimulation index(SI) of spleen lymphocytes from the immunized mice were measured, and the levels of IFN-γ and IL-2 and the activity of antigen-specific CTL were detected. The DNA vaccine-vaccinated BALB/c mice were infected with 1×105 CFU(colony forming unit) MTB H37Rv through tail vein. Four weeks later, the bacteria load in spleen was determined. RESULTS: The titer of serum specific antibody in BALB/c mice immunized with DNA vaccine was 1∶800. The SI of DNA vaccine-immunized groups(2.42±0.13) was significantly higher than that of saline-immunized group. The IFN-γ[(2449±12) ng/L]induced by DNA vaccine was not different from that in bacillus calmette guerin(BCG)-immunized group, while IL-2[(198±16) ng/L] induced by DNA vaccine had significant difference from that of saline-immunized group and was lower than that of BCG-immunized group. The antigen-specific CTL efficacy was 42%. Compared with the saline immunized mice (bacteria load was 6.51±0.13), a dramatic reduction of MTB replication was observed in the spleen (bacteria load was 4.51±0.23, P<0.05) of BALB/c mice immunized with DNA vaccine following a subsequent challenge, but the protective efficacy of DNA vaccine was lower than that of BCG vaccine. CONCLUSION: DNA vaccine expressing ESAT6-CFP10 fusion protein has a immunotherapeutic effect to prevent tuberculosis.